These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16551870)

  • 21. UGT1A1 haplotypes associated with reduced glucuronidation and increased serum bilirubin in irinotecan-administered Japanese patients with cancer.
    Sai K; Saeki M; Saito Y; Ozawa S; Katori N; Jinno H; Hasegawa R; Kaniwa N; Sawada J; Komamura K; Ueno K; Kamakura S; Kitakaze M; Kitamura Y; Kamatani N; Minami H; Ohtsu A; Shirao K; Yoshida T; Saijo N
    Clin Pharmacol Ther; 2004 Jun; 75(6):501-15. PubMed ID: 15179405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic inactivation of laminin-5-encoding genes in lung cancers.
    Sathyanarayana UG; Toyooka S; Padar A; Takahashi T; Brambilla E; Minna JD; Gazdar AF
    Clin Cancer Res; 2003 Jul; 9(7):2665-72. PubMed ID: 12855645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic and HIF-1 regulation of stanniocalcin-2 expression in human cancer cells.
    Law AY; Lai KP; Ip CK; Wong AS; Wagner GF; Wong CK
    Exp Cell Res; 2008 May; 314(8):1823-30. PubMed ID: 18394600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequent inactivation of SPARC by promoter hypermethylation in colon cancers.
    Yang E; Kang HJ; Koh KH; Rhee H; Kim NK; Kim H
    Int J Cancer; 2007 Aug; 121(3):567-75. PubMed ID: 17397030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A DNA methylation signature associated with aberrant promoter DNA hypermethylation of DNMT3B in human colorectal cancer.
    Huidobro C; Urdinguio RG; Rodríguez RM; Mangas C; Calvanese V; Martínez-Camblor P; Ferrero C; Parra-Blanco A; Rodrigo L; Obaya AJ; Suárez-Fernández L; Astudillo A; Hernando H; Ballestar E; Fernández AF; Fraga MF
    Eur J Cancer; 2012 Sep; 48(14):2270-81. PubMed ID: 22244828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer.
    Ogishima T; Shiina H; Breault JE; Tabatabai L; Bassett WW; Enokida H; Li LC; Kawakami T; Urakami S; Ribeiro-Filho LA; Terashima M; Fujime M; Igawa M; Dahiya R
    Clin Cancer Res; 2005 Feb; 11(3):1028-36. PubMed ID: 15709168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia.
    Magdinier F; Wolffe AP
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):4990-5. PubMed ID: 11309512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenotype-genotype correlation of in vitro SN-38 (active metabolite of irinotecan) and bilirubin glucuronidation in human liver tissue with UGT1A1 promoter polymorphism.
    Iyer L; Hall D; Das S; Mortell MA; Ramírez J; Kim S; Di Rienzo A; Ratain MJ
    Clin Pharmacol Ther; 1999 May; 65(5):576-82. PubMed ID: 10340924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TET1 Depletion Induces Aberrant CpG Methylation in Colorectal Cancer Cells.
    Kai M; Niinuma T; Kitajima H; Yamamoto E; Harada T; Aoki H; Maruyama R; Toyota M; Sasaki Y; Sugai T; Tokino T; Nakase H; Suzuki H
    PLoS One; 2016; 11(12):e0168281. PubMed ID: 27977763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA methylation associated with polycomb repression in retinoic acid receptor β silencing.
    Moison C; Senamaud-Beaufort C; Fourrière L; Champion C; Ceccaldi A; Lacomme S; Daunay A; Tost J; Arimondo PB; Guieysse-Peugeot AL
    FASEB J; 2013 Apr; 27(4):1468-78. PubMed ID: 23299856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Down-regulation of PIK3CG, a catalytic subunit of phosphatidylinositol 3-OH kinase, by CpG hypermethylation in human colorectal carcinoma.
    Semba S; Itoh N; Ito M; Youssef EM; Harada M; Moriya T; Kimura W; Yamakawa M
    Clin Cancer Res; 2002 Dec; 8(12):3824-31. PubMed ID: 12473596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene silencing of MIR22 in acute lymphoblastic leukaemia involves histone modifications independent of promoter DNA methylation.
    Li X; Liu J; Zhou R; Huang S; Huang S; Chen XM
    Br J Haematol; 2010 Jan; 148(1):69-79. PubMed ID: 19807731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells.
    Kim TY; Jong HS; Song SH; Dimtchev A; Jeong SJ; Lee JW; Kim TY; Kim NK; Jung M; Bang YJ
    Oncogene; 2003 Jun; 22(25):3943-51. PubMed ID: 12813468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytosine methylation represses glutathione S-transferase P1 (GSTP1) gene expression in human prostate cancer cells.
    Singal R; van Wert J; Bashambu M
    Cancer Res; 2001 Jun; 61(12):4820-6. PubMed ID: 11406558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. UGT1A10 is responsible for SN-38 glucuronidation and its expression in human lung cancers.
    Oguri T; Takahashi T; Miyazaki M; Isobe T; Kohno N; Mackenzie PI; Fujiwara Y
    Anticancer Res; 2004; 24(5A):2893-6. PubMed ID: 15517893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methylation of specific CpG sites in the P2 promoter of parathyroid hormone-related protein determines the invasive potential of breast cancer cell lines.
    Tost J; Hamzaoui H; Busato F; Neyret A; Mourah S; Dupont JM; Bouizar Z
    Epigenetics; 2011 Aug; 6(8):1035-46. PubMed ID: 21775817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic down-regulation of death-associated protein kinase in lung cancers.
    Toyooka S; Toyooka KO; Miyajima K; Reddy JL; Toyota M; Sathyanarayana UG; Padar A; Tockman MS; Lam S; Shivapurkar N; Gazdar AF
    Clin Cancer Res; 2003 Aug; 9(8):3034-41. PubMed ID: 12912953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer.
    Cameron EE; Bachman KE; Myöhänen S; Herman JG; Baylin SB
    Nat Genet; 1999 Jan; 21(1):103-7. PubMed ID: 9916800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucuronidation of 7-ethyl-10-hydroxycamptothecin (SN-38) by the human UDP-glucuronosyltransferases encoded at the UGT1 locus.
    Ciotti M; Basu N; Brangi M; Owens IS
    Biochem Biophys Res Commun; 1999 Jun; 260(1):199-202. PubMed ID: 10381366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrant methylation and silencing of the BNIP3 gene in colorectal and gastric cancer.
    Murai M; Toyota M; Suzuki H; Satoh A; Sasaki Y; Akino K; Ueno M; Takahashi F; Kusano M; Mita H; Yanagihara K; Endo T; Hinoda Y; Tokino T; Imai K
    Clin Cancer Res; 2005 Feb; 11(3):1021-7. PubMed ID: 15709167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.